|
| Advances in Understanding the Pathogenesis of Scleroderma,
Robert Lafyatis, MD
Scleroderma Research Forum, November 21, 2010 |
|
|
|
Dr. Robert Lafyatis is a graduate of the University
of Cincinnati School of Medicine with residencies at North
Carolina Baptist Hospital, Bowman and the National Institutes of Health with
fellowships at
the National Institutes of Health. He presently is a professor of medicine
with major clinical
interests in systemic sclerosis and systemic lupus erythematosus at Boston
University Medical Center. Dr. Lafyatis
carries out patient oriented research into the cause and treatment of
systemic sclerosis. This includes early phase
clinical trials into new therapeutic agents in patients with systemic
sclerosis. He is investigating the mechanisms
of actions and markers of response for novel therapeutics. He is leading an
effort in the study of biomarkers in
systemic sclerosis. The goals of these studies are to find molecular markers
for disease activity and progression that
improve treatment and permit smaller, faster clinical trials. Ongoing
studies include investigation into molecular
markers of pulmonary hypertension in systemic sclerosis. |
| |
Contact |
|
| Scleroderma Foundation Inc Tri-state Chapter Scleroderma Foundation Inc Delaware Valley Chapter
Scleroderma Foundation Inc National Foundation
|
|
|
| Disclaimer:
Neither the Scleroderma Foundation (including its member chapters), nor
Starlight Productions, nor the featured speakers, make any recommendation or
endorsement of any specific treatment, medication or product for any individual.
Patients are advised to consult with their own healthcare professionals
regarding their own treatments. |
| Recording your
event....click here for more information |
|
|
|
|
|
|
|
